Key result
HCM progression is associated with ~82% greater LA dilation and a ventricular transcriptional shift.
Why the study?
Left atrial remodeling is an early and critical feature of hypertrophic cardiomyopathy contributing to atrial fibrillation and thromboembolic risk, but the cellular and transcriptional mechanisms remain incompletely understood.
Observational (n=56)
Answers are grounded in this paper and cite their sources.
May support LA size as HCM progression marker; leaves open transcriptional targets for intervention.
All articles of this category (opens in new window) Background: Left atrial (LA) remodeling is an early and critical feature of hypertrophic cardiomyopathy (HCM), contributing to atrial fibrillation (AF), increased hospitalization, and thromboembolic risk. While LA enlargement and dysfunction are well-recognized, the underlying cellular and transcriptional mechanisms driving this process remain incompletely understood. This study aimed to enhance our understanding of structural and transcriptional changes in the remodeling LA during disease progression in HCM. Methods: To characterize LA remodeling in HCM, we analyzed LA free wall (LAFW) tissue from nine end-stage HCM patients (MYH7: n = 4, MYBPC3: n = 5) and 16 nonfailing donors. Disease progression was studied in a longitudinal MYH7 R403Q Yucatan minipig model with LAFW samples collected at early, intermediate, and late stages (R403Q: n = 15, WT: n = 16; ages 2–13 months). Morphometric features, including CM volume, eccentricity, and nucleation, were quantified using confocal microscopy and deep learning-based 3D image analysis. Transcriptional changes were assessed by single-nucleus RNA sequencing (snRNA-seq) in both species. Results: Three-dimensional volumetric analysis of > 9,500 human CM demonstrated marked hypertrophy in end-stage HCM compared to nonfailing controls. The increase in cell volume was driven by a proportional increase in cell length and width. To further dissect remodeling dynamics, R403Q pigs were examined at defined disease stages. At 6 months, echocardiography revealed significant LA dilation in R403Q animals compared to WT (1,457 ± 203 mm 2 vs. 802 ± 45 mm 2 ; p = 0.043), accompanied by increased fibrosis. Volumetric analysis of > 22,500 CMs showed an approximately 13-fold volume increase over time in R403Q pigs (vs. approximately 4.5-fold in WT; p = 6.4e−41), accompanied by more frequent bi-/multinucleation, which correlated with volume ( r = 0.81, p = 2.0e−8). SnRNA-seq revealed progressive transcriptional reprogramming in mutant CM, marked by a shift from atrial toward ventricular-like gene expression, including a MYH6-to-MYH7 paralog switch. Conclusion: Atrial remodeling in HCM involves progressive CM hypertrophy and a transcriptional shift from atrial to ventricular gene expression. These changes emerge early in MYH7 R403Q pigs and are recapitulated in end-stage human HCM. In MYH7-related HCM, increased atrial expression of the mutant MYH7 allele may further drive atrial myopathy and contribute to the highest incidence of AF in MYH7 HCM. Publication History Article published online: 17 February 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
No takes yet. Share an insight, caveat, or question.
Beyer et al. (2026) conducted an observational in Hypertrophic cardiomyopathy (n=56). Hypertrophic cardiomyopathy (MYH7 R403Q mutation) vs. Nonfailing donors / Wild-type controls was evaluated on Left atrial dilation at 6 months (minipig model, area in mm2) (p=0.043). Hypertrophic cardiomyopathy progression involves significant left atrial dilation and a transcriptional shift from atrial to ventricular gene expression.
Synapse has enriched 10 related papers. Consider them for comparative context: